MedTrace Logo

Adaptive Intervention to Facilitate PrEP Uptake/Adherence Among Transgender Women

NCT05016232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2024-07-25

No results posted yet for this study

Summary

"PrEP N' Shine" is a two-stage randomized controlled pilot trial which utilizes a behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis (PrEP) in Transgender women (TGW).

Conditions

  • Prevention

Interventions

BEHAVIORAL

PrEP N' Shine: Strength Based Case Management (Stage 1)

Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.

BEHAVIORAL

PrEP N' Shine: Stepped Adherence Training and Counseling (Stage 2)

1. Initially TGW in this arm will receive daily 2-way gender-affirming text message reminders, and 2. Then those continuing to have poor adherence will receive the 4 (once per week for 3 to 4 weeks) more intensive counseling session with a clinical interventionist.

Sponsors & Collaborators

Principal Investigators

  • Matthew Mimiaga, ScD, MPH, MA · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-18
Primary Completion
2024-05-31
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05016232 on ClinicalTrials.gov